Biotech Values

[ghmm]

I was trying to think of the HCV deals (which seem to me have been getting less lucrative). Was VRTX's acquisition of Virochem the last big (I know that's relatively but lets say > 100 million up front cash/stock)? I searched and it seems like it was just over a year ago (march '09) and they got $100 million cash and $275 million in Vertex stock.